Pfizer to Sell Georgia Manufacturing Plant to Xethanol
Xethanol Corporation's (New York, NY) subsidiary CoastalXethanol signed a letter of intent with Pfizer Inc. (New York, NY) to purchase Pfizer's pharmaceutical manufacturing complex in Augusta, Georgia.
Xethanol Corporation's (New York, NY, www.xethanol.com) subsidiary CoastalXethanolsigned a letter of intent with Pfizer Inc. (New York, NY, www.pfizer.com) topurchase Pfizer's pharmaceutical manufacturing complex in Augusta,Georgia.
The 40-acre site includes an 89,100-ft2 manufacturingfacility, a25,000-ft2 warehouse facility, 7300-ft2 oflaboratory space, and 16,000-ft2 of offices and conference rooms. CoastalXethanol intends to retrofit the site to produce 35 million gallons per year of ethanol.
The facility will produce ethanol from cellulosic and other biomasswaste streams generated by industrial producers in the surroundingareas. CoastalXethanol may produce biodiesel in this facility underXethanol's sublicense from H2Diesel, Inc.
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
